Innovation 20main 20space
Innovation 20logo

Shaping the future of health care by uniting promising innovators with the best minds in science and medicine at the member institutions of the Texas Medical Center.

About this Accelerator

TMC Innovation was created to attract the latest and greatest in health technology to the world’s largest medical center and establish Houston’s hub for medical innovation. Through the past several years, TMC Innovation has progressively supported healthcare startups from around the world with strategic programming and unique services alongside the member institutions of the Texas Medical Center. We serve our 60+ institutions through a variety of programs applicable to multiple stages of a start up's life cycle. We work specifically with startups working in medical device, digital health, and cancer therapeutics, as well as with aspiring healthcare entrepreneurs. See below for an overview of some of our offerings.


The TMCx Accelerator is a six-month program for early-stage medical device and digital health start-ups from around the world, designed to drive meaningful relationships between the best emerging technology and our Texas Medical Center institutions and corporate partners.

Throughout the program, companies are set up for success through a tailored curriculum and one on one meetings with our extensive advisor network. Here, they will gain insights in every facet of running a health-related business, from clinical trials and FDA regulations to procurement, intellectual property, and fundraising and everything in-between. Participants have a chance to refine their business and clinical strategies and continue to iterate and validate their solutions with seasoned executives, clinical leaders, and subject matter experts.

TMCx is tailored to support companies who have demonstrated proof of concept to pilot, codevelop, and scale with multiple partners. The TMC Innovation team collaborates with each medical device or digital health company through strategic introductions across the world’s largest medical complex. Embedded industry and academic partners provide world class strategic insights on the pathways to market. Startups that experience TMCx expect success.


The TMC Biodesign Program is a one-year, full time, paid fellowship program for aspiring entrepreneurs that brings together talented post-grad individuals worldwide from various backgrounds—including medicine, engineering, business, computer science, design, and research— to create solutions for healthcare’s greatest unmet needs. Fellows are mentored by the Innovation team and an expert network through a proven development process that encompasses both product and business life cycles.

Separated into two development tracks, digital health and medical device, fellows and their teammates delve into the Biodesign program. Our teams are fully immersed into the clinical experience, shadowing physicians, sourcing needs, and ideating potential solutions. Through this unique fellowship opportunity, fellows gain the fundamentals necessary to transform ideas into products, and products into new startup companies.


The ACT program is a CPRIT funded accelerator launched, in collaboration with the Gulf Coast Consortium (GCC) and the University of Texas Medical Branch (UTMB), to support Texas-based biotech entrepreneurs, researchers contemplating translational development, and internal comprehensive drug development programs. TMC ACT aims to support Texas based cancer therapeutic company growth, increasing the overall success rate while decreasing the development time.

ACT participants will gain insight into every facet of developing a cancer therapeutics company. During the 9-month program, participants will gain a deep understanding of market research, FDA regulations, intellectual property, licensing, finance, fundraising, legal, and other critical areas that will propel your business for long term success. Program participants will develop an integrated strategic development plan based on industry best practices that guides their company’s business and drug development efforts. ACT culminates with at least one grant submission, and an option to pitch to investors, corporate partners, media, and other influential guests.


  • Houston, TX, USA


Biotechnology, Business Services, Chemicals and Chemical Products, Electronics / Instrumentation, Healthcare Services + 5 more